ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,365, issued on March 18, was assigned to AbbVie Inc. (North Chicago, Ill.) and AbbVie Deutschland Gmbh & Co. KG (Wiesbaden, Germany).
"Pharmaceutical formulations for subcutaneous administration" was invented by Ehab Moussa (Libertyville, Ill.), Matthew Rosebraugh (Grayslake, Ill.), Feroz Jameel (Gurnee, Ill.), Nancy Sever (Northbrook, Ill.), Maurizio F. Facheris (Chicago), Weining Z Robieson (Hawthorn Woods, Ill.), Charles S. Locke (Gurnee, Ill.) and Sven Stodtmann (Neustadt an der Weinstrasse, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions of levodopa 4'-monophosphate and carbidopa 4'-monopho...